CBI Scene Blog

Direct-to-Patient, Remote Trials, Site-less Trials, and Digital Trials Different Ways of Saying 'Trial Success' and 'Positive Patient Experiences'

Importance of Validation and Verification of MES Recipes

Q&A with Matthew Amsden, Founder and CEO of ProofPilot

Q&A With the 2018 Trailblazer Award Recipients

Strategies for Deploying and Using Life Sciences Product Complaint Thresholds

4 Key MES Implementation Considerations

How to Align Management with Functional Areas of R&D

GDPR's Impact on Consent Management and Data Privacy

The Underestimated Importance of Ground Transportation for Meetings & Events

What Will Be the Next Hot Technology at Life Sciences Events?

CBI Highlights Rare Disease Day with CureCMT4J

Put One (Green) Foot In Front Of The Other – Sustainability in Meeting Planning

Bridging the Generation Gap in Communication – Balancing Face-to-Face Networking with Online Communication

Find Your Fire! Top 5 Stress Busters for Busy Meeting Professionals

Importance of Listening to the "Voice of the Customer"

Monitoring and Auditing with Limited Resources – How Often Should Comprehensive Risk Assessments Be Done?

5 Meeting Location Alternatives to the Traditional Exhibit Hall

Keeping It SiMMPle (Strategic Meeting Management: Practical Light and Effective) Part 3

The Challenges of Scaling Up: Globalization of Call Centers

How to Use Technology to Keep Meeting Participants Interested and Involved

Business Travel Tips 101: Pharmaceutical Meeting Planner Edition

Keeping It SiMMPle (Strategic Meeting Management: Practical Light and Effective) Part 2

Strategy for Attendee Acquisition for Life Sciences Meetings

Virtual Meeting vs. Destination Meeting: Which is the Right Choice?

Moving from “Call Center” to Multi-Channel Center

A Walk through the Pharma Forum 2018 Agenda

Information Security at Life Sciences Meetings

From Stoop To Stage: Pharma Forum 2018 Keynote Announced

3 More Tips for Planning and Executing Compliant and Successful Life Sciences Meetings

5 Tips for Combating Compliance and Policy Challenges in the Execution of Global Pharmaceutical Meetings

How to Know You’re Keeping Your (Clinical Trial Supplies) Cool

Keeping It SiMMPle (Strategic Meeting Management: Practical Light and Effective)

Establishing HCP Meal Limits for Life Sciences Meetings

The Best and Brightest: A Peek into the Pharma Forum Audience

A Letter from the Pharma Forum Program Director

Meet Pharma Forum's 2018 Advisory Board

Pharma Forum's 2018 CSR Activity: TOMS® shoes

Launching an Orphan Drug: A Case Study by AmerisourceBergen

Acing CRA Interviews – The Ball is in Your Court

The Changing Role of the CRA in an RBM World

Q&A With Executive Director of the Center for Lawful Access and Abuse Deterrence (CLAAD) on the Challenges and Future of ADFs

Biosimilars: European Versus US Market

Q&A With Editor and Chief of CIO Magazine and Events on Pharma Enterprise Customer Data Integration

Best Practices for Cohesive Global Compliance Programs in Latin America

Effective Global Access Programs within an International Regulatory Landscape

EFPIA Transparency Directive and Data Privacy in EU: 3 Clear Patterns

Why Should ADFs (Abuse Deterrent Formulations) Be Mandatory?

Advertising Targeting for Healthcare & Life Sciences in the 21st Century

Inside Secrets: The Future of Abuse Deterrent Formulations

Harnessing Digital Platforms for HCP Engagement in Emerging Markets

6 Reasons Why iPharma 2015 is Your Life Sciences Marketing Event

7 Useful App Features For Life Sciences Conferences

Patient Access Network Foundation: Celebrating 10 Years of Supporting Patients and Families

Promoting Health and Wellness at Meetings and Events

The Future of Global Transparency of HCP Data

The Pharma Forum 2015 Agenda is Your One-Hit Holiday Wonder

Unique Challenges When Commercializing Specialty Drugs & How to Mitigate Risk

5 Best Practices to Secure Enterprise-Wide Buy-In for Master Data Management

INFOGRAPHIC: Seizing a Rare Opportunity- A Current Snapshot of the Rare Disease Community

The Major Barriers of Entry for Therapeutic Discoveries for Rare Disease Conditions

5 Initiatives to Advance Research into Rare Disease Therapies

Howard Doffman, VP & General Counsel at Ferring Pharmaceuticals on Social Media

INFOGRAPHIC: The Evolution of Clinical Technology

How Genetics Advancements Are Paving Way for Opportunities in Rare Disease Research, Diagnosis & Treatment

5 Tips to Manage Transparency & Aggregate Spend Dispute Resolution

How to Establish Effective Global Transparency Reporting

An Analysis on Effectiveness Evidence in FDA's Approval of Orphan Drugs

Requirements for Open Payments Reporting for Clinical Research

eCoupons Offer Adherence and Patient Engagement Opportunities

How to Prepare for Public Disclosure of Sunshine Data

How to Standardize IRT Implementation and Management

Tips on mHealth & Healthy Habits

Why Attend Medicaid 2014? The Reasons Are Endless...

Are Grey Areas In The Sunshine Act Leaving Manufacturers in a Fog?

What to Consider When Implementing an eTMF – And What Vendors May Not Tell You

5 Tips on How Your Content Marketing Can Improve Your Pharma Brand

7 Useful App Features For Pharmaceutical & Biotechnology Conventions

FAQs about Pharma and Medical Meeting Apps

iPharma 2014- What's All the Hype About?

How the ePatient Will Revolutionize Pharma Marketing

Leverage Technological Advancements to Achieve Financial Transformation

Strategic Patient Adherence Awards - Excellence in Patient Adherence

Platform Technology vs Point Solutions – Are We Our Own Worst Enemy?

Beyond Ourselves- Embracing Open Innovation in Clinical Development

Why Pharma Marketers Need to Start Coloring Outside the Lines

Evolving Pharma Accounting Challenges in the International Arena

Why Pharma Marketers Need to Focus on Smart Data Rather Than Big Data

How You Can Design a Clinical Trial With Technology That's Ahead-of-the-Curve

Why Wearable Technology Will Change Your Pharma Marketing Strategy

Streamlining Operational & Functional Processes in Global Clinical Trials

How Pharma Marketers can Prepare for Loss of Exclusivity (LOE)

Are F2F Corporate Meetings & Events Relevant in a Digital Era?

How International Meeting Managers & HCPs Can Work Together

How to Effectively Manage Social Media at Medical Meetings

The Full Clinical Trial Data Transparency & Limited Disclosure Debate

Facing the Future: Embracing the Evolution in Medical Meeting Planning

INFOGRAPHIC: Innovations in Oncology Therapy & Research

How AdvaMED & PhRMA Codes Impact Planning for Medical Meetings

Creating & Maintaining the ‘Standard’: 5 Ways to Enhance Your GTN Performance

What Meeting Managers Should Expect After the Sunshine Act Reports

What if Vendors Created Their Own TransCelerate?

Proving the ROI of Strategic Global Meetings

The PHARMA FORUM 2014 Agenda is Now Ready!

CBI Risk-Based Monitoring Conference Debrief - CluePoints’ POV

CMPP Certification Program – An Interview with ISMPP

5 Things to Consider When Planning Global Meetings

Patient-Centric Trial May Determine if the Cloud Can Help Diabetics

How to Solve Patient Retention & Compliance Problems with Patient Reminders

Harry Potter’s Severus Snape & Big Pharma, a Comparison

A Cautionary Tale as You Prepare for an FDA Advisory Committee Meeting

Content Connections: Mark Linver, Huron Life Sciences

The Retail Pharmacy Phenomenon – What it Means for Pharma Marketers

Content Connections: Patricia A. Tietbohl (Johnson & Johnson)

Need for Speed: A Chat with Joel W. Beetsch of Celgene

Challenging Pharma’s “Bad Rep”

Point-of-Care: The Patient Friendly Form of Direct-to-Consumer

The World of Clinical Trials According to Jim DiCesare

Moving to the Cloud – 5 Tips To Help You Develop Your Cloud Strategy

Why is Point of Care Marketing so Important?

Speed to Therapy: A 5K Dash to Therapy Initiation

How to Integrate ABAC Processes To Ensure Third Party Compliance

Top Ten Takeaways from CBI's Global Transparency Reporting Congress

CBI's Aggregate Spend Series -- How It All Began and Where It's Going

Maintaining Brand Reputation in the Event of a Product Recall

Musings on the AMP Final Rule & Other Fun Tidbits from Steven Moore

The EMA Disclosure Mandate – A Shift for Clinical Trial Data Sharing

Why is Social Media So Important for Patient Online Reporting?

Event Mobile App Engagement: How to Drive Attendee Participation

The Pharma Distribution Supply Chain: Going Global

It’s Not Just About the Sunshine Act – 3 Other Areas of Compliance Focus in 2013

Medical Device Excise Tax (MDET) Conversation Intensifies

Five Tips to Help Healthcare Marketers Reach Target Audiences

How Healthcare Reform Will Affect Your Patient Assistance Strategy

INFOGRAPHIC: Rare Disease Day 2013 by Siren Interactive

Are You Certifiable? - New Subspecialty Certification for Meeting Professionals

INFOGRAPHIC: Global Meetings for Pharma and Medical Industries

Announcing CBI's Blog Series: CBI Scene!

Subscribe to CBI Scene Blog

Latest Posts